Cardiac patients
A recent study published in the Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease has found that guidelines issued by the American Heart Association/American College of Cardiology/Heart Failure Society of America have had a significant impact on Medicare drug coverage policies for two life-saving medications used
Drug approval
Dr. George Tidmarsh, the FDA's top drug regulator, has resigned after being accused of soliciting a bribe and tanking a company's stock as part of an alleged revenge plot against a former colleague, Kevin Tang. Tidmarsh was accused in a lawsuit of retaliating against Tang starting
Associations
Editas Medicine, a pioneering gene editing company, will present a digital poster presentation at the upcoming American Heart Association (AHA) Scientific Sessions 2025, showcasing its transformative LDL cholesterol-lowering in vivo CRISPR gene editing medicine. The presentation, titled "A transformative LDL cholesterol-lowering in vivo CRISPR gene editing medicine that functionally
Cardiac patients
A recent study published in the Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease has found that guidelines issued by the American Heart Association/American College of Cardiology/Heart Failure Society of America have had a significant impact on Medicare drug coverage policies for two life-saving medications used
Antipsychotic agents
Research from the University of Siena details new data on the advantages and disadvantages of oral and long-acting injectable antipsychotic medications for treating schizophrenia. The study, published in International Clinical Psychopharmacology, aimed to support clinicians in choosing the most suitable formulation based on clinical symptoms. Financial support for the research
Associations
Researchers at CREATE Medicines, a clinical-stage biotech company, have reported preliminary clinical results from the Phase 1 MYE Symphony trial of MT-302, an in vivo mRNA-LNP CAR therapy designed to treat solid tumors. The results demonstrate the potential of this approach to overcome the limitations of traditional CAR therapies, which
Antipsychotic agents
Research from the University of Siena details new data on the advantages and disadvantages of oral and long-acting injectable antipsychotic medications for treating schizophrenia. The study, published in International Clinical Psychopharmacology, aimed to support clinicians in choosing the most suitable formulation based on clinical symptoms. Financial support for the research
Children's Hospital Medical Center
Researchers at Cincinnati Children's Hospital Medical Center, in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that can predict which drugs may cause harmful immune reactions in certain individuals. This innovative platform uses induced pluripotent stem cell-derived liver organoids combined with each donor'
Anti-obesity agents
The World Anti-Doping Agency (WADA) is monitoring the use of GLP-1 weight loss drugs by athletes, particularly in endurance sports, which could lead to a ban before the 2028 Olympics in Los Angeles. This has sparked concerns that the Los Angeles Games might be remembered as the "Ozempic Olympics&
Drugs
The Karnataka state government is exploring a new approach to ensuring the quality of manufactured drugs, after initial plans to establish an independent agency for quality checks faced challenges. In response to appeals from city pharmacists, the government is considering introducing voluntary inspections, operating under the Quality Council of India
Drugs
Researchers at the University of Michigan have developed a mathematical model that reveals how our circadian rhythms can have dramatic impacts on how our bodies interact with medicines. This model could help doctors prescribe medicines to have the best intended effect by syncing the dosing with the natural clocks of
Drugs
Fall enrollment in Medicare is underway, and millions of beneficiaries are shopping for prescription drug coverage. While some plans are raising premiums by $50 or more per month, others are lowering them. KFF, a health care research nonprofit, found that only a few national drug plans were raising premiums substantially
